Forecast & Rating4 analysts currently cover Elicio Therapeutics, of which 3 give a positive rating. The average price target is $20.00, about 547.2% upside from the current price of $3.09. Coverage is limited, so the data is for reference only. Data as of Jul 2, 2026; this does not constitute investment advice.
Jul 2, 2026
Price forecast
$20.00547.25%
Forecast & RatingBuy
4analysts
Strong buy75.00%
Buy0.00%
Hold25.00%
Sell0.00%
Strong sell0.00%
Strong buy
3
Buy
0
Hold
1
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 19, 2026
Forecast met73.4%
Stock price$3.09
Average forecast price$15.5
Highest forecast price$18
Lowest forecast price$13
Average forecast price
$15.5
Highest forecast price
$18
Lowest forecast price
$13
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.